| scholarly article | Q13442814 |
| editorial | Q871232 |
| P2093 | author name string | C William Helm | |
| P2860 | cites work | Intraperitoneal chemotherapy for the initial management of primary epithelial ovarian cancer | Q24235235 |
| Prognostic factors for stage III epithelial ovarian cancer treated with intraperitoneal chemotherapy: a Gynecologic Oncology Group study. | Q30359038 | ||
| Hyperthermic intraperitoneal chemotherapy with carboplatin for optimally-cytoreduced, recurrent, platinum-sensitive ovarian carcinoma: a pilot study | Q33405507 | ||
| Pharmacokinetic rationale for peritoneal drug administration in the treatment of ovarian cancer | Q34055165 | ||
| Hyperthermic intraperitoneal chemotherapy with cisplatin and paclitaxel in advanced ovarian cancer: a multicenter prospective observational study | Q34996992 | ||
| What is the optimal goal of primary cytoreductive surgery for bulky stage IIIC epithelial ovarian carcinoma (EOC)? | Q36484029 | ||
| Postoperative mortality after primary cytoreductive surgery for advanced stage epithelial ovarian cancer: a systematic review | Q37432638 | ||
| Evolution of surgical treatment paradigms for advanced-stage ovarian cancer: redefining 'optimal' residual disease. | Q37988243 | ||
| Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy as upfront therapy for advanced epithelial ovarian cancer: multi-institutional phase-II trial. | Q43765205 | ||
| Thermal Enhancement of New Chemotherapeutic Agents at Moderate Hyperthermia | Q44431967 | ||
| Cytoreductive surgery and intraoperative hyperthermic intraperitoneal chemotherapy with paclitaxel: a clinical and pharmacokinetic study | Q44449632 | ||
| Hyperthermic intraperitoneal chemotherapy after extensive cytoreductive surgery in patients with primary advanced epithelial ovarian cancer: interim analysis of a phase II study | Q46147063 | ||
| Secondary cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for recurrent epithelial ovarian cancer: a multi-institutional study. | Q47787815 | ||
| HIPEC in recurrent ovarian cancer patients: morbidity-related treatment and long-term analysis of clinical outcome. | Q50788596 | ||
| Cytoreductive surgery and HIPEC in recurrent epithelial ovarian cancer: a prospective randomized phase III study. | Q53081680 | ||
| Intraperitoneal cisplatin and paclitaxel in ovarian cancer. | Q53263238 | ||
| Evaluation of Extensive Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Patients With Advanced Epithelial Ovarian Cancer | Q58766454 | ||
| Intraperitoneal hyperthermic chemotherapy using carboplatin: a phase I analysis in ovarian carcinoma | Q80325049 | ||
| P433 | issue | 1 | |
| P921 | main subject | ovarian cancer | Q172341 |
| P304 | page(s) | 1-2 | |
| P577 | publication date | 2015-01-01 | |
| P1433 | published in | Journal of gynecologic oncology | Q26842232 |
| P1476 | title | Hyperthermic intraperitoneal chemotherapy for ovarian cancer: is there a role? | |
| P478 | volume | 26 |
| Q47151877 | Neoadjuvant chemotherapy followed by fast-track cytoreductive surgery plus short-course hyperthermic intraperitoneal chemotherapy (HIPEC) in advanced ovarian cancer: preliminary results of a promising all-in-one approach | cites work | P2860 |
Search more.